SEC Comment Letter 0000000000-23-003483 to BIOVIE INC. (BIVI)
BIOVIE INC.
Date: April 6, 2023 · CIK: 0001580149 · Accession: 0000000000-23-003483
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-271054
Letter
United States securities and exchange commission logo April 6, 2023 Wendy Kim Chief Financial Officer BIOVIE INC. 680 W Nye Lane Suite 204 Carson City, NV 89703 Re:BIOVIE INC. Registration Statement on Form S-3 Filed March 31, 2023 File No. 333-271054 Dear Wendy Kim: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jimmy McNamara at 202-551-7349 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Michael Lee
Show Raw Text
United States securities and exchange commission logo
April 6, 2023
Wendy Kim
Chief Financial Officer
BIOVIE INC.
680 W Nye Lane Suite 204
Carson City, NV 89703
Re:BIOVIE INC.
Registration Statement on Form S-3
Filed March 31, 2023
File No. 333-271054
Dear Wendy Kim:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jimmy McNamara at 202-551-7349 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Michael Lee